Literature DB >> 11293284

Long-term follow-up of children with retinoblastoma.

M P Nahum1, M Gdal-On, A Kuten, G Herzl, Y Horovitz, M Weyl Ben Arush.   

Abstract

Twenty-one pediatric retinoblastoma (RB) patients treated between 1976 and 1994 were evaluated for late treatment-related complications. Median age at diagnosis was 24 months; median age at follow-up was 12 years; median follow-up time was 12 years. Of the 21 patients, 14 had unilateral RB and 7 had bilateral RB. Thirteen patients had received external radiotherapy and 8 children were treated by chemotherapy. Twenty-one patients had undergone enucleation. Radiation-induced cataracts were found in 3 patients, radiation retinopathy in 1, enucleation and postradiotherapy contracted socket in 1, very low visual acuity postradiotherapy in 3, severe hypotelorism in 2, growth hormone deficiency in 2, neurocognitive disorders in 6, and orbital deformation due to radiation bone atrophy was moderate-severe in 12 patients. Azoospermia was found in 1 patient treated by cyclophosphamide and vincristine. The most frequent sequela in this group of RB-cured children were postradiotherapy orbital deformation due to bone atrophy and neurocognitive disabilities. Late radiation effects must be avoided by using modern, innovative, and more sophisticated radiotherapeutic techniques. Late treatment-related complications justify the long-term follow-up of childhood RB survivors.

Entities:  

Mesh:

Year:  2001        PMID: 11293284     DOI: 10.1080/08880010151114769

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  14 in total

1.  Developmental and adaptive functioning in children with retinoblastoma: a longitudinal investigation.

Authors:  Victoria W Willard; Ibrahim Qaddoumi; Si Chen; Hui Zhang; Rachel Brennan; Carlos Rodriguez-Galindo; Matthew W Wilson; Sean Phipps
Journal:  J Clin Oncol       Date:  2014-07-14       Impact factor: 44.544

Review 2.  A systematic review of selected musculoskeletal late effects in survivors of childhood cancer.

Authors:  Prasad L Gawade; Melissa M Hudson; Sue C Kaste; Joseph P Neglia; Karen Wasilewski-Masker; Louis S Constine; Leslie L Robison; Kirsten K Ness
Journal:  Curr Pediatr Rev       Date:  2014

3.  Chronic medical conditions in adult survivors of retinoblastoma: Results of the Retinoblastoma Survivor Study.

Authors:  Danielle Novetsky Friedman; Joanne F Chou; Kevin C Oeffinger; Ruth A Kleinerman; Jennifer S Ford; Charles A Sklar; Yuelin Li; Mary S McCabe; Leslie L Robison; Brian P Marr; David H Abramson; Ira J Dunkel
Journal:  Cancer       Date:  2016-01-11       Impact factor: 6.860

4.  Cognitive function and social attainment in adult survivors of retinoblastoma: a report from the St. Jude Lifetime Cohort Study.

Authors:  Tara M Brinkman; Thomas E Merchant; Zhenghong Li; Rachel Brennan; Matthew Wilson; Mary Ellen Hoehn; Ibrahim Qaddoumi; Sean Phipps; Deokumar Srivastava; Leslie L Robison; Melissa M Hudson; Kevin R Krull
Journal:  Cancer       Date:  2014-11-24       Impact factor: 6.860

5.  A longitudinal investigation of parenting stress in caregivers of children with retinoblastoma.

Authors:  Victoria W Willard; Ibrahim Qaddoumi; Hui Zhang; Lu Huang; Kathryn M Russell; Rachel Brennan; Matthew W Wilson; Carlos Rodriguez-Galindo; Sean Phipps
Journal:  Pediatr Blood Cancer       Date:  2016-11-03       Impact factor: 3.167

Review 6.  Progress in Small Molecule Therapeutics for the Treatment of Retinoblastoma.

Authors:  Eleanor M Pritchard; Michael A Dyer; R Kiplin Guy
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

7.  Management of radiation-induced severe anophthalmic socket contracture in patients with uveal melanoma.

Authors:  Qasiem J Nasser; Dan S Gombos; Michelle D Williams; B Ashleigh Guadagnolo; William H Morrison; Adam S Garden; Beth M Beadle; Elvia Canseco; Bita Esmaeli
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2012 May-Jun       Impact factor: 1.746

8.  Pharmacokinetics and efficacy of the spleen tyrosine kinase inhibitor r406 after ocular delivery for retinoblastoma.

Authors:  Eleanor M Pritchard; Elizabeth Stewart; Fangyi Zhu; Cori Bradley; Lyra Griffiths; Lei Yang; Praveen Kumar Suryadevara; Jiakun Zhang; Burgess B Freeman; R Kiplin Guy; Michael A Dyer
Journal:  Pharm Res       Date:  2014-06-07       Impact factor: 4.200

9.  Mechanism study of isoflavones as an anti-retinoblastoma progression agent.

Authors:  Qifeng Wu; He Bai; Chu-Long Huang; Yongming Zhang; Xiayun Zeng; Huan Wan; Wen Zuo; Hai-Ying Wang; Yi-Xin Zeng; Yan-Dong Wang
Journal:  Oncotarget       Date:  2017-07-18

10.  Long-term follow-up of retinoblastoma survivors: Experience from India.

Authors:  Rachna Seth; Amitabh Singh; Vijay Guru; Bhavna Chawla; Sushmita Pathy; Savita Sapra
Journal:  South Asian J Cancer       Date:  2017 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.